IP Library Granted Patent US 12,491,074
Granted Patent B2
US 12,491,074 · App. 17/755,749 · Granted Dec 9, 2025

Composite implant for total meniscus reconstruction

Inventor: Michael G. Dunn (Manalapan, NJ)
Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
A61F2/30756A61F2/30749A61F2/30965A61F2002/30056A61F2002/30062A61F2002/3008A61F2002/30131A61F2002/30677A61F2002/30766A61F2/3872A61F2310/00011A61F2310/00359
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,491,074
App. No.
17/755,749
Granted
Dec 9, 2025
Kind
B2
Abstract

Artificial meniscal scaffolds characterized by a composite of circumferential polymer fiber network and orthogonal polymer fiber network embedded in an arcuate bioresorbable matrix comprised of collagen and hyaluronic acid. The orthogonal polymer fiber network prevents separation of the circumferential polymer fiber networks. The polymer fiber networks convert axial compressive forces on the scaffolds to tensile loads on the circumferential polymer fibers. The composite scaffold can be anchored to bone by novel anchoring components that protect the polymer fibers and ensure immediate securement of the artificial meniscal scaffold to bone.

Claims (15)

1 . An artificial meniscal scaffold for placement in a knee joint, the artificial meniscal scaffold comprising:

an arcuate bioresorbable matrix;

a network of circumferential bioresorbable fibers embedded in said matrix; and

a network of orthogonal bioresorbable fibers embedded in said matrix to prevent separation of said circumferential fiber network;

wherein the bioresorbable circumferential fibers and the bioresorbable orthogonal fibers have a three-dimensional shape and geometry which is substantially the same as the three-dimensional shape and geometry of the matrix;

wherein the scaffold is comprised of an anterior end, a posterior end, and a middle section therebetween defining a curved path between said anterior and posterior ends;

wherein the network of circumferential bioresorbable fibers extends between said anterior and posterior ends along the path of said curve and exits the anterior and posterior ends of the scaffold to form respective anterior and posterior attachment segments;

wherein the anterior and posterior attachment segments have a proximal region, a distal region, a length, and an exterior surface;

wherein a polymeric fiber is wound multiple times around at least a portion of an exterior surface of the middle section to protect the circumferential and orthogonal bioresorbable fibers embedded in the arcuate bioresorbable matrix;

wherein the polymeric fiber is laced through holes in the arcuate bioresorbable matrix and secured by knots to the exterior surface of the middle section of the arcuate bioresorbable matrix; and,

wherein the artificial meniscal scaffold is a C-shaped disc with a wedge-like cross-section.

2 . The artificial meniscal scaffold of claim 1 , wherein the matrix is comprised of a radiopaque material containing iodine, barium, tantalum, bismuth, or gold.

3 . The artificial meniscal scaffold of claim 1 , wherein the matrix is comprised of platelet rich plasma or mammalian cells.

4 . The artificial meniscal scaffold of claim 1 , wherein the matrix is comprised of an antimicrobial agent, antibiotic, or anti-fungal agent.

5 . The artificial meniscal scaffold of claim 1 , wherein the matrix is comprised of bone derivatives or calcium-phosphate compounds.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 12, 2022
From: RUTGERS, THE STATE UNIVERSITY OF N.J.
To: UNITED STATES GOVERNMENT
Reel/Frame 061663/0760 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2022
From: DUNN, MICHAEL G.
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 059843/0823 →
Continuity (2)
Provisional Application 62931500 · Nov 6, 2019
Related Publication 20220401220A1 · Dec 22, 2022
References Cited (14)
US 6103255A · Levene et al. · 2000 [cited by applicant]
US 7157428B2 · Kusanagi et al. · 2007 [cited by applicant]
US 9078756B2 · Gatt et al. · 2015 [cited by applicant]
US 20030078617A1 · Schwartz · 2003 [cited by examiner]
US 20030125744A1 · Contiliano et al. · 2003 [cited by applicant]
US 20080255665A1 · Weissberg · 2008 [cited by examiner]
US 20100168864A1 · White · 2010 [cited by examiner]
US 20120232656A1 · Gedet · 2012 [cited by examiner]
US 20140222149A1 · Amis · 2014 [cited by examiner]
US 20140243911A1 · Almarza et al. · 2014 [cited by applicant]
US 20160193033A1 · Murray et al. · 2016 [cited by applicant]
US 20160235545A1 · Linder-Ganz · 2016 [cited by examiner]
US 20170007411A1 · Khan et al. · 2017 [cited by applicant]
EP 1493404A1 · 2005 [cited by applicant]